Table of Contents

1 Market Overview
1.1 Subcutaneous Immunoglobulins Introduction
1.2 Market Analysis by Type
1.2.1 10% Purity
1.2.2 20% Purity
1.3 Market Analysis by Applications
1.3.1 Primary Immunodeficiency
1.3.2 Secondary Immunodeficiency
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA Market States and Outlook (2012-2022)
1.4.1.2 Canada Market States and Outlook (2012-2022)
1.4.1.3 Mexico Market States and Outlook (2012-2022)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2012-2022)
1.4.2.2 France Market States and Outlook (2012-2022)
1.4.2.3 UK Market States and Outlook (2012-2022)
1.4.2.4 Russia Market States and Outlook (2012-2022)
1.4.2.5 Italy Market States and Outlook (2012-2022)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2012-2022)
1.4.3.2 Japan Market States and Outlook (2012-2022)
1.4.3.3 Korea Market States and Outlook (2012-2022)
1.4.3.4 India Market States and Outlook (2012-2022)
1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2012-2022)
1.4.4.2 Egypt Market States and Outlook (2012-2022)
1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
1.4.4.4 South Africa Market States and Outlook (2012-2022)
1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Shire (Baxalta)
2.1.1 Business Overview
2.1.2 Subcutaneous Immunoglobulins Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Shire (Baxalta) Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Grifols
2.2.1 Business Overview
2.2.2 Subcutaneous Immunoglobulins Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Grifols Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 CSL
2.3.1 Business Overview
2.3.2 Subcutaneous Immunoglobulins Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 CSL Subcutaneous Immunoglobulins Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Subcutaneous Immunoglobulins Market Competition, by Manufacturer
3.1 Global Subcutaneous Immunoglobulins Sales and Market Share by Manufacturer
3.2 Global Subcutaneous Immunoglobulins Revenue and Market Share by Manufacturer
3.3 Market Concentration Rate
3.3.1 Top 3 Subcutaneous Immunoglobulins Manufacturer Market Share
3.3.2 Top 6 Subcutaneous Immunoglobulins Manufacturer Market Share
3.4 Market Competition Trend
4 Global Subcutaneous Immunoglobulins Market Analysis by Regions
4.1 Global Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Regions
4.1.1 Global Subcutaneous Immunoglobulins Sales by Regions (2012-2017)
4.1.2 Global Subcutaneous Immunoglobulins Revenue by Regions (2012-2017)
4.2 North America Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
4.3 Europe Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
4.4 Asia-Pacific Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
4.5 South America Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
4.6 Middle East and Africa Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
5 North America Subcutaneous Immunoglobulins by Countries
5.1 North America Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Countries
5.1.1 North America Subcutaneous Immunoglobulins Sales by Countries (2012-2017)
5.1.2 North America Subcutaneous Immunoglobulins Revenue by Countries (2012-2017)
5.2 USA Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
5.3 Canada Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
5.4 Mexico Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
6 Europe Subcutaneous Immunoglobulins by Countries
6.1 Europe Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Countries
6.1.1 Europe Subcutaneous Immunoglobulins Sales by Countries (2012-2017)
6.1.2 Europe Subcutaneous Immunoglobulins Revenue by Countries (2012-2017)
6.2 Germany Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
6.3 UK Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
6.4 France Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
6.5 Russia Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
6.6 Italy Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
7 Asia-Pacific Subcutaneous Immunoglobulins by Countries
7.1 Asia-Pacific Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Subcutaneous Immunoglobulins Sales by Countries (2012-2017)
7.1.2 Asia-Pacific Subcutaneous Immunoglobulins Revenue by Countries (2012-2017)
7.2 China Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
7.3 Japan Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
7.4 Korea Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
7.5 India Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
7.6 Southeast Asia Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
8 South America Subcutaneous Immunoglobulins by Countries
8.1 South America Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Countries
8.1.1 South America Subcutaneous Immunoglobulins Sales by Countries (2012-2017)
8.1.2 South America Subcutaneous Immunoglobulins Revenue by Countries (2012-2017)
8.2 Brazil Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
8.3 Argentina Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
8.4 Columbia Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
9 Middle East and Africa Subcutaneous Immunoglobulins by Countries
9.1 Middle East and Africa Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Subcutaneous Immunoglobulins Sales by Countries (2012-2017)
9.1.2 Middle East and Africa Subcutaneous Immunoglobulins Revenue by Countries (2012-2017)
9.2 Saudi Arabia Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
9.3 UAE Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
9.4 Egypt Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
9.5 Nigeria Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
9.6 South Africa Subcutaneous Immunoglobulins Sales and Growth (2012-2017)
10 Global Subcutaneous Immunoglobulins Market Segment by Type
10.1 Global Subcutaneous Immunoglobulins Sales, Revenue and Market Share by Type (2012-2017)
10.1.1 Global Subcutaneous Immunoglobulins Sales and Market Share by Type (2012-2017)
10.1.2 Global Subcutaneous Immunoglobulins Revenue and Market Share by Type (2012-2017)
10.2 10% Purity Sales Growth and Price
10.2.1 Global 10% Purity Sales Growth (2012-2017)
10.2.2 Global 10% Purity Price (2012-2017)
10.3 20% Purity Sales Growth and Price
10.3.1 Global 20% Purity Sales Growth (2012-2017)
10.3.2 Global 20% Purity Price (2012-2017)
11 Global Subcutaneous Immunoglobulins Market Segment by Application
11.1 Global Subcutaneous Immunoglobulins Sales Market Share by Application (2012-2017)
11.2 Primary Immunodeficiency Sales Growth (2012-2017)
11.3 Secondary Immunodeficiency Sales Growth (2012-2017)
11.4 Others Sales Growth (2012-2017)
12 Subcutaneous Immunoglobulins Market Forecast (2017-2022)
12.1 Global Subcutaneous Immunoglobulins Sales, Revenue and Growth Rate (2017-2022)
12.2 Subcutaneous Immunoglobulins Market Forecast by Regions (2017-2022)
12.2.1 North America Subcutaneous Immunoglobulins Market Forecast (2017-2022)
12.2.2 Europe Subcutaneous Immunoglobulins Market Forecast (2017-2022)
12.2.3 Asia-Pacific Subcutaneous Immunoglobulins Market Forecast (2017-2022)
12.2.4 South America Subcutaneous Immunoglobulins Market Forecast (2017-2022)
12.2.5 Middle East and Africa Subcutaneous Immunoglobulins Market Forecast (2017-2022)
12.3 Subcutaneous Immunoglobulins Market Forecast by Type (2017-2022)
12.4 Subcutaneous Immunoglobulins Market Forecast by Application (2017-2022)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source